Page 364 - IJB-10-3

International Journal of Bioprinting hNVU chip for brain modeling and drug screening

4. Jessa S, Blanchet-Cohen A, Krug B, et al. Stalled 15. Verscheijden LFM, van Hattem AC, Pertijs JCLM, et al.
developmental programs at the root of pediatric brain Developmental patterns in human blood–brain barrier and
tumors. Nat Genet. 2019;51:1702-1713. blood–cerebrospinal fluid barrier ABC drug transporter
doi: 10.1038/s41588-019-0531-7 expression. Histochem Cell Biol. 2020;154:265-273.
5. Mackay A, Burford A, Carvalho D, et al. Integrated doi: 10.1007/s00418-020-01884-8
molecular meta-analysis of 1,000 pediatric high-grade and 16. Partap S, Monje M. Pediatric brain tumors. Continuum
diffuse intrinsic pontine glioma. Cancer Cell. 2017;32(4): (Minneap Minn). 2020;26:1553-1583.
520-537.e5. doi: 10.1212/CON.0000000000000955
doi: 10.1016/j.ccell.2017.08.017
17. Leary SES, Kilburn L, Geyer JR, et al. Vorinostat and
6. Ray S. Tumorsphere formation assay: a cancer stem-like cell isotretinoin with chemotherapy in young children with
characterization in pediatric brain cancer medulloblastoma. embryonal brain tumors: a report from the Pediatric
In: Bhakat KK, Hazra TK, eds. Base Excision Repair Pathway. Brain Tumor Consortium (PBTC-026). Neuro Oncol.
Methods in Molecular Biology, vol. 2701. New York, NY: 2022;24(7):1178-1190.
Humana; 2023. doi: 10.1093/neuonc/noab293
doi: 10.1007/978-1-0716-3373-1_17
18. Lam S, Lin Y, Warnke PC. Permeability imaging in pediatric
7. Mo J, Anastasaki C, Chen Z. Humanized neurofibroma brain tumors. Transl Pediatr. 2014;3(3):218-228.
model from induced pluripotent stem cells delineates tumor doi: 10.3978/j.issn.2224-4336.2014.07.01
pathogenesis and developmental origins. J Clin Invest.
2021;131(1):e139807. 19. Langen UH, Ayloo S, Gu C. Development and cell biology
doi: 10.1172/JCI139807 of the blood‒brain barrier. Annu Rev Cell Dev Biol.
2019;35:591-613.
8. Maurange C. Temporal patterning in neural progenitors: doi: 10.1146/annurev-cellbio-100617-062608
from Drosophila development to childhood cancers. Dis
Model Mech. 2020;13(7):dmm044883. 20. Arvanitis CD, Ferraro GB, Jain RK. The blood–brain barrier
doi: 10.1242/dmm.044883 and blood–tumor barrier in brain tumors and metastases.
Nat Rev Cancer. 2020;20:26-41.
9. Lin S, Li K, Qi L. Cancer stem cells in brain tumors: from doi: 10.1038/s41568-019-0205-x
origin to clinical implications. MedComm. 2023;4:e341.
doi: 10.1002/mco2.341 21. Venneti S, Thompson CB. Metabolic reprogramming in
brain tumors. Annu Rev Pathol. 2017;12:515-545.
10. Mascelli S, Raso A, Biassoni R, et al. Analysis of NADP+- doi: 10.1146/annurev-pathol-012615-044329
dependent isocitrate dehydrogenase-1/2 gene mutations
in pediatric brain tumors: report of a secondary anaplastic 22. Maoz B, Herland A, FitzGerald EA, et al. A linked organ-
astrocytoma carrying the IDH1 mutation. J Neurooncol. on-chip model of the human neurovascular unit reveals the
2012;109(3):477-484. metabolic coupling of endothelial and neuronal cells. Nat
doi: 10.1007/s11060-012-0925-1 Biotechnol. 2018;36:865-874.
doi: 10.1038/nbt.4226
11. Dubuc AM, Northcott PA, Mack S, Witt H, Pfister S, Taylor
MD. The genetics of pediatric brain tumors. Curr Neurol 23. Kim J, Lee KT, Lee JS, et al. Fungal brain infection modeled
Neurosci Rep. 2010;10:215-223. in a human-neurovascular-unit-on-a-chip with a functional
doi: 10.1007/s11910-010-0103-9 blood–brain barrier. Nat Biomed Eng. 2021;5:830-846.
doi: 10.1038/s41551-021-00743-8
12. Deng MY, Sturm D, Pfaff E, et al. Radiation-induced gliomas
represent H3-/IDH-wild type pediatric gliomas with 24. Ahn SI, Sei YJ, Park HJ, et al. Microengineered human blood–
recurrent PDGFRA amplification and loss of CDKN2A/B. brain barrier platform for understanding nanoparticle
Nat Commun. 2021;12:5530. transport mechanisms. Nat Commun. 2020;11:175.
doi: 10.1038/s41467-021-25708-y doi: 10.1038/s41467-019-13896-7
13. Kitange GJ, Carlson BL, Schroeder MA, et al. Induction 25. Lyu Z, Park J, Kim KM, et al. A neurovascular-unit-on-
of MGMT expression is associated with temozolomide a-chip for the evaluation of the restorative potential of
resistance in glioblastoma xenografts. Neuro-Oncol. stem cell therapies for ischemic stroke. Nat Biomed Eng.
2009,11(3):281-291. 2021;5:847-863.
doi: 10.1215/15228517-2008-090 doi: 10.1038/s41551-021-00744-7
14. Alnahhas I, Alsawas M, Rayi A, et al. Characterizing benefit 26. Ouyang L, Armstrong JPK, Chen Q, Lin Y, Stevens MM.
from temozolomide in MGMT promoter unmethylated and Void-free 3D bioprinting for in situ endothelialization
methylated glioblastoma: a systematic review and meta- and microfluidic perfusion. Adv Funct Mater. 2020;
analysis. Neuro-Oncol Adv. 2020;3(1):vdaa082. 30:1908349.
doi: 10.1093/noajnl/vdaa082 doi: 10.1002/adfm.201908349

Volume 10 Issue 3 (2024) 356 doi: 10.36922/ijb.1684